Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024

1. Europe POCT Device Market Europe POCT Device Market to Grow at a CAGR of over 8.6% Through 2024 Europe POCT Device Market is expected to reach USD 11.68bin 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Blood Glucose testing kits market has the largest market segment in Euope POCT device market. Browse Full Report and Details TOC: https://databridgemarketresearch.com/reports/europe-poct-device-market/

2. Report Description The Europe POCT Device Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Roche dominated the Euope POCT device market market accounting for the highest market share in 2016, followed by Siemens and Abbott. Other players in this market include Alere Inc., Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc. among others holds 41.1% of the Europe POCT device market in 2016. Request For Free Sample Report: https://databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market

3. Key Drivers • Rising cost of POCT devices is the factor which may hinder the growth of this market. • Many companies are making continuous efforts and advancesto make products more up to date, along with propelled innovations with reduced sample volume or less blood on portable devices. So as to create development for in-vitro diagnostics organizations in the market. • Emerging POCT device market as well as emergence of Microfluidic lab-on-a-chip technologieswill drive the market in future. Speak to Expert: https://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-poct-device-market

4. Recent Developments: • In May, 2017, Abbott announced CE Mark approval and its use of the new Rx Insertable Cardiac Monitor (ICM), which is the world’s first smartphone compatible ICM to identify or detect cardiac arrhythmias, including atrial fibrillation (AF), for therapy. • In May, 2017, Abbott announced the national reimbursement for freestyle Libre in France, providing access to revolutionary technology for people suffering with diabetes. This would help thousands of people to have access to test type 1 and type 2 diabetes. Request for Customization @ sopan.gedam@databridgemarketresearch.com

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : Sopan Gedam+1-888-387-2818 (Toll Free) sopan.gedam@databridgemarketresearch.com